CxGELSIX: A novel preparation of type VI collagen with possible use as a biomaterial

Cornea

Volumn 19, Issue 2, 2000, Pages 194-203

  Lekskul, Manapon ^a   Burrows, Robert ^a   Kublin, Claire L ^a   Cintron, Charles ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

ig; Biomaterial; Cornea; CxGelsix; Gelsix; Stroma; Type VI collagen

Indexed keywords

BIOMATERIAL; COLLAGEN TYPE 4;

ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CELL ULTRASTRUCTURE; CORNEA EPITHELIUM; CROSS LINKING; DEVICE; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RABBIT; STROMA CELL; TRANSMISSION ELECTRON MICROSCOPY; WOUND HEALING;

ANIMALS; BIOCOMPATIBLE MATERIALS; COLLAGEN; CORNEAL STROMA; CROSS-LINKING REAGENTS; EPITHELIUM, CORNEAL; POLYETHYLENE GLYCOLS; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RABBITS; WOUND HEALING;

EID: 0034048830     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200003000-00013     Document Type: Article

References (49)

1. Zimmermann DR, Trüeb B, Winterhalter KH, Witmer R, Fischer RW. Type VI collagen is a major component of the human cornea. FEBS Lett 1986;197:55-8.
2. Trüeb B, Schreier T, Bruckner P, Winterhalter KH. Type VI collagen represents a major fraction of connective tissue collagens. Eur J Biochem 1987;166:699-703.
3. Kuo H-J, Keene R, Glanville W. The macromolecular structure of type VI collagen: formation and stability of filaments. Eur J Biochem 1995;232:364-72.
4. 1, integrin and NG2, during avian corneal stromal development. Invest Ophthalmol Vis Sci 1998;39:263-75.
5. Tillet E, Ruggiero F, Nishiyama A, Stallcup WB. The membranespanning proteoglycan NG2 binds to collagens V and VI through the central nonglobular domain of its core protein. J Biol Chem 1997;272:10769-76.
6. Vogel KG, Paulsson M, Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984;223:587-97.
7. Koller E, Winterhalter KH, Trüeb B. The globular domains of type VI collagen are related to the collagen-binding domains of cartilage matrix protein and von Willebrand factor. EMBO J 1989;8:1073-7.
8. 3, chain indicate a bridging role for chicken collagen VI in connective tissues. Biochemistry 1990;29:1245-54.
9. Takahashi T, Cho H-I, Kublin C L, Cintron C. Keratan sulfate and dermatan sulfate proteoglycans associate with type VI collagen in fetal rabbit cornea. J Histochem Cytochem 1993;41:1447-57.
10. McDevitt CA, Marcelino J, Tucker L. Interaction of intact type-VI collagen with hyaluronan. FEBS Lett 1991;294:167-70.
11. Kielty CM, Whittaker SP, Grant ME, Shuttleworth CA. Type VI collagen microfibrils: evidence for a structural association with hyaluronan. J Cell Biol 1992;118:979-90.
12. Bidanset DJ, Guidry C, Rosenberg LC, Choi HU, Timpl R, Hook M. Binding of the proteoglycan decorin to collagen type VI. J Biol Chem 1992;267:5250-6.
13. Hoylaerts MF, Yamamoto H, Nuyts K, Vreys I, Deckmyn H, Vermylen J. von Willebrand factor binds to native collagen VI primarily via its Al domain. Biochem J 1997;324:185-91.
14. 3(VI) chain of type VI collagen. J Biol Chem 1997;272:22817-23.
15. Burg MA, Tillet E, Timpl R, Stallcup WB. Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules. J Biol Chem 1996;271:26110-6.
16. Keene DR, Engvall E, Glanville RW. Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network. J Cell Biol 1988;107:1995-2006.
17. Cintron C, Hong B-S. Heterogeneity of collagens in rabbit cornea: type VI collagen. Invest Ophthalmol Vis Sci 1988;29:760-6.
18. Rawe IM, Zhan Q, Burrows R, Bennett K, Cintron C. βig: molecular cloning and in situ hybridization in corneal tissues. Invest Ophthalmol Vis Sci 1997;38:893-900.
19. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β. DNA Cell Biol 1992;7:511-22.
20. Zinn K, MacAllister L, Goodman CS. Sequence analysis and neuronal expression of fasciculin I in grasshopper and Drosophila. Cell 1988;53:577-87.
21. Takeshita X, Kikuno R, Tezuka K, Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciculin I. Biochem J 1993;294:271-8.
22. Gibson MA, Hatzinikolas G, Kumaratilake JS, et al. Further characterization of proteins associated with elastic fiber microfibrils including the molecular cloning of MAGP-2 (MP 25). J Biol Chem 1996;271:1096-103.
23. Hashimoto K, Noshiro M, Ohno S, et al. Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/βig-h3) that binds to collagen. Biochim Biophys Acta 1997;1355:303-14.
24. Gibson MA, Kumaratilake JS, Cleary EG. Immunohistochemical and ultrastructural localization of MP78/70 (βig-h3) in extracellular matrix of developing and mature bovine tissues. J Histochem Cytochem 1997;45:1683-96.
25. Doane KJ, Yang G, Birk DE. Corneal cell-matrix interactions: type VI collagen promotes adhesion and spreading of corneal fibroblasts. Exp Cell Res 1992;200:490-9.
26. Skonier J, Bennett K, Rothwell V, et al. βig-h3: a transforming growth factor-β-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 1994;13:571-84.
27. LeBaron RG, Bezverkov KI, Zimber MP, Pavelec R, Skonier J, Purchio AF. βig-h3: a novel secretory protein inducible by transforming growth factor-β, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J Invest Dermatol 1995;104:844-9.
28. Lee SD, Hsiue GH, Chang PC, Kao CY. Plasma-induced grafted polymerization of acrylic acid and subsequent grafting of collagen onto polymer film as biomaterials. Biomaterials 1996;17:1599-1608.
29. Desgrange P, Tardieu M, Loisance D, Barritault D. Extracellular matrix covered biomaterials for human endothelial cell growth. Int J Artif Organs 1992;15:722-6.
30. Rhee W, Wallace DG, Michaels AS, et al. Collagen-polymer conjugates: patent number 5,162,430: date of patent: Nov. 10, 1992.
31. Kelman CD, DeVore DP. Collagen-based adhesives and sealants and methods of preparation and use thereof: patent number: 5,219,895. date of patent: June 15, 1993.
32. Kelman CD, DeVore DP. Method for bonding soft tissue with collagen-based adhesives and sealants: patent number: 5,354,336: date of patent: Oct. 11, 1994.
33. Orgill DP, Ehret FW, Regan JF, Glowacki J, Mulliken JB. Polyethylene glycol/microfibrillar collagen composite as a new resorbable hemostatic bone wax. J Biomed Mater Res 1998;39:358-63.
34. Thompson KP, Hanna KD, Gipson IK, Gravagna P, Waring GO III, Johnson-Wint B. Synthetic epikeratoplasty in rhesus monkeys with human type IV collagen. Cornea 1993;12:35-45.
35. van Luyn MJA, Khouw MSL, van Wachem PB, Blaauw IH, Werkmeister JA. Modulation of the tissue reaction to biomaterials: II. the function of T cells in the inflammatory reaction to crosslinked collagen implanted in T-cell-deficient rats. J Biomed Mater Res 1998;39:398-406.
36. van Wachem PB, van Luyn MJA, Damink LO, Dijkstra PJ, Feijen J, Neiuwenhuis P. Biocompatibility and tissue regenerating capacity of crosslinked dermal sheep collagens. J Biomed Mater Res 1994;28:353-63.
37. Werkmeister JA, Edwards GA, Casagranda F, White JF, Ranshaw JAM. Evaluation of a collagen-based biosynthetic material for the repair of abdominal wall defects. J Biomed Mater Res 1998;39:429-36.
38. Chiou AG-Y, Mermoud A, Underdahl JP, Schnyder CC. An ultrasound biomicroscopic study of eyes after deep sclerectomy with collagen implant. Ophthalmology 1998;105:746-50.
39. Fujioka K, Maeda M, Hojo T, Sano A. Protein release from collagen matrices. Adv Drug Delivery Rev 1998;31:247-66.
40. Cintron C, Schneider H, Kublin C. Corneal scar formation. Exp Eye Res 1973;17:251-9.
41. Everts V, Korper W, Neihof A, Jansen I, Beertsen W. Type VI collagen is phagocytosed by fibroblasts and digested in the lysosomal apparatus: involvement of collagenase, serine proteinases and lysosomal enzymes. Matrix Biol 1994;14:665-76.
42. Cintron C, Covington H, Kublin CL. Morphogenesis of rabbit corneal stroma. Invest Ophthalmol Vis Sci 1983;24:543-56.
43. Mast BA, Krummel TM. Acute inflammation in fetal wound healing. In: Adzick NS, Longaker MT, eds. Fetal wound healing. New York: Elsevier, 1992:227-40.
44. Fitton JH, Ziegelaar BW, Hicks CR, et al. Assessment of anticollagenase treatments after insertion of a keratoprosthetic material in the rabbit cornea. Cornea 1998;17:108-14.
45. Tang L, Eaton W. Inflammatory responses to biomaterials. Am J Clin Pathol 1995;103:466-71.
46. Herzlinger GA, Bing DH, Stein R, Cumming RD. Quantitative measurement of C3 activation at polymer surfaces. Blood 1981;57:764-70.
47. Kochounian H, Maxweell A, Gupta A. Complement activation by surface modified poly-methyl methacrylate intraocular lenses. J Cataract Refract Surg 1991;17:139-42.
48. Verhagen C, Breebaart A, Kijlstra A. The effects of C' depletion on corneal inflammation in rats. Invest Ophthalmol Vis Sci 1992;33:273-9.
49. Ito H-O, Ueda T, Imoto T, Koga T. Prevention of collagen-induced arthritis (CIA) by treatment with polyethylene glycol-conjugated type II collagen; distinct tolerogenic property of the conjugated collagen from the native one. Clin Exp Immunol 1997;108:213-9.